We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




DNA-Based Analysis Detects Group A Streptococcus

By LabMedica International staff writers
Posted on 27 Oct 2016
Print article
Image: A Petri dish with Group A Streptococcus-inoculated trypticase soy agar containing 5% defibrinated sheep\'s blood (Photo courtesy of Richard R. Facklam, PhD).
Image: A Petri dish with Group A Streptococcus-inoculated trypticase soy agar containing 5% defibrinated sheep\'s blood (Photo courtesy of Richard R. Facklam, PhD).
As an exclusively human pathogen, Group A Streptococcus (GAS; Streptococcus pyogenes) is spread in the community through direct human-to-human transmission and GAS can also colonize a healthy host without any apparent clinical signs or symptoms.

In clinical microbiology, standard cultivation methods are considered the ‘gold standard’ for microorganism detection because the phenotypic characterization of clinical isolates is important for determining the treatment directions, but such methods are laborious and time-consuming.

Medical microbiologist at the Tokyo Medical and Dental University (Japan) and their colleagues collected throat swab samples from October 2013 to June 2014 from students and staff from various departments of the university. Two throat swabs were collected from the upper pharyngeal region of each of the 148 volunteers. One swab was dipped into 500 μL of sterile Trypticase soy broth for the culture-dependent study. The other swab was dipped into 600 μL of the sterile bead solution from the PowerSoil DNA isolation kit (MO BIO Laboratories, Carlsbad, CA, USA) and stored.

Two methods, culture dependent and independent, were used to detect GAS in throat swabs from healthy adults. For the culture-dependent method, swabs were streaked onto two types of agar medium and in addition to streaking; each throat swab dipped tryptic soy broth (TSB) and was also added to 1.2 mL of fresh TSB for enrichment. For the culture-independent study DNA extracted from the other was amplified by polymerase chain reaction (PCR) with two GAS-specific primer pairs: one was a newly designed 16S rRNA-specific primer pair, the other a previously described V-Na+-ATPase primer pair. The cloned PCR products were sequenced using M13 primers and the 3130 Genetic Analyzer (Applied Biosystems, Foster City CA, USA).

The scientists found that although only five (3.4%) of the 148 samples were GAS-positive by the culture-dependent method, 146 (98.6%) were positive for the presence of GAS DNA by the culture-independent method. To obtain serotype information by M type protein gene (emm) typing, they performed nested PCR using newly designed emm primers. They detected the four different emm types in 25 (16.9%) samples, and these differed from the common emm types associated with GAS associated diseases in Japan. The different emm types detected in the healthy volunteers indicate that the presence of unique emm types might be associated with GAS carriage.

The authors concluded that culture-independent methods should be considered for profiling GAS in the healthy hosts, with a view to obtaining better understanding of these organisms. The GAS-specific primers (16S rRNA and V-Na+-ATPase) used in this study can be used to estimate the maximum potential GAS carriage in people. These results suggest that not only school-age children, but also healthy adults can serve as GAS carriers. The study was published on October 11, 2016, in the journal BMC Microbiology.

Related Links:
Tokyo Medical and Dental University
MO BIO Laboratories
Applied Biosystems
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Benchtop Cooler
PCR-Cooler & PCR-Rack

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.